Sangmi Oh

Dr. Sangmi Oh

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2011 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
SOSangmi Oh
Sangmi Oh
Seung Bum ParkSeung Bum Park
Seung Bum Park
We demonstrated the importance of maximized skeletal diversity of privileged substructures for the construction of a drug-like small-molecule library through a series of high-throughput screening and subsequent bioevaluations. Our divergent pDOS strategy can provide an efficient approach for the discovery of novel small-molecule modulators with excellent specificity.

30 June 2021 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
BRBenjamin Ruf
Benjamin Ruf
VCVanessa V. Catania
Vanessa V. Catania
SWSimon Wabitsch
Simon Wabitsch
CMChi Ma
Chi Ma
LDLaurence P. Diggs
Laurence P. Diggs
TGTim F. Greten
Tim F. Greten
Mucosal-associated invariant T (MAIT) cells are MR1-restricted innate-like T cells that recognize non-peptide antigens including riboflavin derivates. Although in vitro–activated MAIT cells show antitumor activity, the in vivo role of MAIT cells in cancer is still unclear. Here, we have shown that MAIT cells have antitumor function in vivo when activated by a combination of the synthetic riboflavin synthesis pathway–derived antigen 5-OP-RU [5-(2-oxopropylideneamino)-6-D-ribitylaminouracil] and the Toll-like receptor 9 (TLR9) agonist CpG. Coadministration of 5-OP-RU and CpG induced strong systemic in vivo expansion and activation of MAIT cells with high CD69 expression, pronounced effector memory phenotype, and upregulated levels of effector molecules including IFNγ, granzyme B, and perforin. Activated and expanded MAITs induced a potent and broad antitumor immune response in murine models of liver metastasis and hepatocellular carcinoma, lung metastasis, and subcutaneous tumors in two different mouse strains. Such tumor inhibition was absent in MAIT-deficient Mr1−/− mice. CRISPR/Cas9-mediated MR1 knockout in tumor cells did not affect efficacy of this MAIT-directed immunotherapy, pointing toward an indirect mechanism of action. Our findings suggest that MAIT cells are an attractive target for cancer immunotherapy. See related Spotlight by Lantz, p. 996.

1 October 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YXYuan-Bin Xie
Yuan-Bin Xie
JPJeong-Hoh Park
Jeong-Hoh Park
DKDon-Kyu Kim
Don-Kyu Kim
JHJung Hwan Hwang
Jung Hwan Hwang
SOSangmi Oh
Sangmi Oh
HCHueng-Sik Choi
Hueng-Sik Choi
SMILE (small heterodimer partner interacting leucine zipper protein) has been identified as a corepressor of the glucocorticoid receptor, constitutive androstane receptor, and hepatocyte nuclear factor 4α. Here we show that SMILE also represses estrogen receptor-related receptor γ (ERRγ) transactivation. Knockdown of SMILE gene expression increases ERRγ activity. SMILE directly interacts with ERRγ in vitro and in vivo. Domain mapping analysis showed that SMILE binds to the AF2 domain of ERRγ. SMILE represses ERRγ transactivation partially through competition with coactivators PGC-1α, PGC-1β, and GRIP1. Interestingly, the repression of SMILE on ERRγ is released by SIRT1 inhibitors, a catalytically inactive SIRT1 mutant, and SIRT1 small interfering RNA but not by histone protein deacetylase inhibitor. In vivo glutathione S-transferase pulldown and coimmunoprecipitation assays validated that SMILE physically interacts with SIRT1. Furthermore, the ERRγ inverse agonist GSK5182 enhances the interaction of SMILE with ERRγ and SMILE-mediated repression. Knockdown of SMILE or SIRT1 blocks the repressive effect of GSK5182. Moreover, chromatin immunoprecipitation assays revealed that GSK5182 augments the association of SMILE and SIRT1 on the promoter of the ERRγ target PDK4. GSK5182 and adenoviral overexpression of SMILE cooperate to repress ERRγ-induced PDK4 gene expression, and this repression is released by overexpression of a catalytically defective SIRT1 mutant. Finally, we demonstrated that ERRγ regulates SMILE gene expression, which in turn inhibits ERRγ. Overall, these findings implicate SMILE as a novel corepressor of ERRγ and recruitment of SIRT1 as a novel repressive mechanism for SMILE and ERRγ inverse agonist.


1 September 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SOSangmi Oh
Sangmi Oh
SKSungbum Kim
Sungbum Kim
SKSunju Kong
Sunju Kong
GYGyongseon Yang
Gyongseon Yang
NLNakyung Lee
Nakyung Lee
RSRita Song
Rita Song

1 June 2010 in Journal of Combinatorial Chemistry
Verified
Journal Article
Closed access
SOSangmi Oh
Sangmi Oh
HJHwan Jong Jang
Hwan Jong Jang
SKSung Kon Ko
Sung Kon Ko
YKYeonjin Ko
Yeonjin Ko
Seung Bum ParkSeung Bum Park
Seung Bum Park